Astellas Pharma (4503) Investor presentation summary

Vision and approach to sustainability

• Focus on transforming innovative science into value for patients by balancing outcomes and healthcare costs.

• Sustainability strategy centers on contributing to society through core business and creating a positive cycle for both company and societal sustainability.

• Updated materiality matrix to prioritize nine key sustainability issues and two environmental priorities.

Key achievements and initiatives

• Enhanced access to health and reduced environmental burden, with visualized non-financial initiatives.

• Strengthened talent pipeline, succession planning, and introduced unified organizational values and health goals.

• Board strengthened with independent directors and deeper, more strategic discussions.

Corporate value visualization and social impact

• Non-financial value (roots) is foundational for future financial value (trunk and branches).

• Social impact monetized: product impact far exceeds human capital, environmental, and access to health impacts.

• Environmental negative impact reduced by 19% since FY2018 despite increased sales.

• Access to health impact calculated by both reach and per capita effect, with ongoing expansion through healthcare system programs.